Evidence map›Paper›PMID 35327007›Full record

ArticleHealthcare (Basel, Switzerland)2022

Spontaneous Pneumo-Mediastinum in a Post-COVID-19 Patient with Systemic Sclerosis.

Ilaria Mormile, Mauro Mormile, Gaetano Rea, Angelica Petraroli, Vittoria Barbieri, Amato de Paulis, Francesca Wanda Rossi

Open access · goldAbstract readCase Reports
In one paragraph

Article in Healthcare (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Long COVID in autoimmune rheumatic diseases.Rheumatology international · 2023
    Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ilaria MormileDepartment of Translational Medical Sciences, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0001-7599-5426
Mauro MormileDepartment of Clinical Medicine and Surgery, University of Naples Federico II, 80131 Naples, Italy.
Gaetano ReaDepartment of Radiology, "Vincenzo Monaldi" Hospital-AORN Ospedale Dei Colli, 80131 Naples, Italy.
Angelica PetraroliDepartment of Translational Medical Sciences, University of Naples Federico II, 80131 Naples, Italy.
Vittoria BarbieriPost-Graduate Program in Clinical Immunology and Allergy, University of Naples Federico II, 80131 Naples, Italy.
Amato de PaulisDepartment of Translational Medical Sciences, University of Naples Federico II, 80131 Naples, Italy.
Francesca Wanda RossiDepartment of Translational Medical Sciences, University of Naples Federico II, 80131 Naples, Italy.
University of Naples Federico II · ITOspedale Monaldi · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary involvement is the most common cause of death among patients with systemic sclerosis (SSc). The current coronavirus disease 2019 (COVID-19) is particularly problematic to manage in SSc patients since they may experience a more severe evolution of COVID-19 due to the pre-existent interstitial lung disease (ILD) and the administration of immunosuppressive treatments. In addition, the remarkable radiological similarities between SSc-ILD and COVID-19 complicate the differential diagnosis between these two entities. Herein, we present the first case of spontaneous pneumo-mediastinum in a post-COVID-19 patient with SSc. In our patient, both smoking and pulmonary fibrosis could lead to cyst formation, which possibly spontaneously broke and caused pneumo-mediastinum. Moreover, megaesophagus perforation due to the smooth muscle atrophy, replacement with fibrosis, and achalasia may extend into the mediastinum or pleural space and has also been described as a rare case of spontaneous pneumo-pericardium. Finally, spontaneous pneumo-mediastinum and pneumothorax have been recently reported as an established complication of severe COVID-19 pneumonia and among COVID-19 long-term complication. This case report underlines that the worsening of respiratory symptoms in SSc patients, especially when recovered from COVID-19, requires further investigations for ruling out other tentative diagnoses besides the evolution of the SSc-ILD.

Indexed as

interstitial lung diseasepneumo-mediastinumpost-COVID-19 syndromepulmonary emphysemasystemic sclerosis

Identifiers

PMID35327007
PMCPMC8953142
OpenAlexW4220960000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.